Literature DB >> 15077145

PML nuclear bodies and apoptosis.

Yuki Takahashi1, Valérie Lallemand-Breitenbach, Jun Zhu, Hugues de Thé.   

Abstract

Promyelocytic leukaemia nuclear bodies (PML NBs) are structured protein complexes associated with the nuclear matrix. PML constitutes the scaffold component of NBs and recruits onto these domains a striking variety of proteins, many of which are involved in apoptosis control. Several reports have directly implicated PML in apoptosis and senescence, but the mechanisms by which these are conveyed are still largely unsettled. Recruitment of partner proteins onto NBs is regulated by PML sumolation, a specific post-translational modification also found in many NB-associated proteins. Among these, several are implicated in transcription repression or activation, like the transcriptional repressor Daxx or the transcriptional activator P53. Whether NBs constitute platforms where active sites of enzymatic modifications are carried out, as suggested for P53, sites of intranuclear protein sequestration, as proposed for Daxx or organelles specialized in catabolism, is still debated. A variety of stress-related signalling pathways dramatically modulate the formation of PML NBs, which may provide a clue as to their physiological function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15077145     DOI: 10.1038/sj.onc.1207533

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  68 in total

1.  Distinct in vivo dynamics of vertebrate SUMO paralogues.

Authors:  Ferhan Ayaydin; Mary Dasso
Journal:  Mol Biol Cell       Date:  2004-09-29       Impact factor: 4.138

Review 2.  PML nuclear bodies.

Authors:  Valérie Lallemand-Breitenbach; Hugues de Thé
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-21       Impact factor: 10.005

3.  Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells.

Authors:  Sabrina Schreiner; Peter Wimmer; Hüseyin Sirma; Roger D Everett; Paola Blanchette; Peter Groitl; Thomas Dobner
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

4.  Dynamics of telomeres and promyelocytic leukemia nuclear bodies in a telomerase-negative human cell line.

Authors:  Thibaud Jegou; Inn Chung; Gerrit Heuvelman; Malte Wachsmuth; Sabine M Görisch; Karin M Greulich-Bode; Petra Boukamp; Peter Lichter; Karsten Rippe
Journal:  Mol Biol Cell       Date:  2009-02-11       Impact factor: 4.138

5.  SUMO conjugation to the matrix attachment region-binding protein, special AT-rich sequence-binding protein-1 (SATB1), targets SATB1 to promyelocytic nuclear bodies where it undergoes caspase cleavage.

Authors:  Joseph-Anthony T Tan; Yujie Sun; Jing Song; Yuan Chen; Theodore G Krontiris; Linda K Durrin
Journal:  J Biol Chem       Date:  2008-04-11       Impact factor: 5.157

Review 6.  Virion factors that target Daxx to overcome intrinsic immunity.

Authors:  Sabrina Schreiner; Harald Wodrich
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

7.  Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.

Authors:  Nirojini Sivachandran; Christopher W Dawson; Lawrence S Young; Fei-Fei Liu; Jaap Middeldorp; Lori Frappier
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

8.  Caspase-1 is a direct target gene of ETS1 and plays a role in ETS1-induced apoptosis.

Authors:  Huiping Pei; Chunyang Li; Yair Adereth; Tien Hsu; Dennis K Watson; Runzhao Li
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

9.  Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: the M. D. Anderson Cancer Center experience of 349 patients.

Authors:  Nikolay D Dimov; L Jeffrey Medeiros; Hagop M Kantarjian; Jorge E Cortes; Kun-Sang Chang; Carlos E Bueso-Ramos; Farhad Ravandi
Journal:  Cancer       Date:  2010-01-15       Impact factor: 6.860

10.  Death domain-associated protein DAXX promotes ovarian cancer development and chemoresistance.

Authors:  Wei-Wei Pan; Jian-Jie Zhou; Xiao-Man Liu; Ying Xu; Lian-Jun Guo; Chao Yu; Qing-Hua Shi; Heng-Yu Fan
Journal:  J Biol Chem       Date:  2013-03-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.